ReGen’s Collagen Scaffold Efficacy Data Questioned By Panel
This article was originally published in The Gray Sheet
Executive Summary
ReGen Biologics' Collagen Scaffold appears safe and effective for knee cartilage repair but provides uncertain clinical benefits, FDA's Orthopedic and Rehabilitation Devices Panel concluded at its Nov. 14 meeting in Gaithersburg, Md
You may also be interested in...
FDA Questions Data Supporting ReGen's Menaflex Ahead Of 510(k) Re-Review
FDA raised concerns about the preclinical and clinical data used to support 510(k) clearance of ReGen Biologic's Menaflex knee repair device ahead of an unprecedented March 23 advisory panel to reconsider FDA's original clearance decision
FDA Questions Data Supporting ReGen's Menaflex Ahead Of 510(k) Re-Review
FDA raised concerns about the preclinical and clinical data used to support 510(k) clearance of ReGen Biologic's Menaflex knee repair device ahead of an unprecedented March 23 advisory panel to reconsider FDA's original clearance decision
Device Center Discord: 510(k) Review Process Is Flash Point At CDRH
Details trickling into the public sphere about CDRH's device review process reveal heightened tension between reviewers and management over the proper response to a 510(k) submission